
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
Zanella, E. R., Galimi, F., Sassi, F., Migliardi, G., Cottino, F., Leto, S. M., Lupo, B., Erriquez, J., Isella, C., Comoglio, P. M., Medico, E., Tejpar, S., Budinska, E., Trusolino, L., Bertotti, A.Volume:
7
Langue:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.3010445
Date:
January, 2015
Fichier:
PDF, 3.08 MB
english, 2015